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Cervical cancer, mainly caused by infection with human papillomaviruses (HPVs), is a major public health problem in Mexico. During a
study of the prevalence of HPV types in northeastern Mexico, we identified, as expected from worldwide comparisons, HPV-16, 18, 31, and 35
as highly prevalent. It is well known that the genomes of HPV types differ geographically because of evolution linked to ethnic groups
separated in prehistoric times. As HPV intra-type variation results in pathogenic differences, we analyzed genomic sequences of Mexican
variants of these four HPV types. Among 112 HPV-16 samples, 14 contained European and 98 American Indian (AA) variants. This ratio is
unexpected as people of European ethnicity predominate in this part of Mexico. Among 15 HPV-18 samples, 13 contained European and 2
African variants, the latter possibly due to migration of Africans to the Caribbean coast of Mexico. We constructed phylogenetic trees of HPV-
31 and 35 variants, which have never been studied. Forty-six HPV-31 isolates from Mexico, Europe, Africa, and the United States (US)
contained a total of 35 nucleotide exchanges in a 428-bp segment, with maximal distances between any two variants of 16 bp (3.7%), similar to
those between HPV-16 variants. The HPV-31 variants formed two branches, one apparently the European, the other one an African branch. The
European branch contained 13 of 29 Mexican isolates, the African branch 16 Mexican isolates. These may represent the HPV-31 variants of
American Indians, as a 55% prevalence of African variants in Mexico seems incomprehensible. Twenty-seven HPV-35 samples from Mexico,
Europe, Africa, and the US contained 11 mutations in a 893-bp segment with maximal distances between any two variants of only 5 mutations
(0.6%), including a characteristic 16-bp insertion/deletion. These HPV-35 variants formed several phylogenetic clusters rather than two- or
three-branched trees as HPV-16, 18, and 31. An HPV-35 variant typical for American Indians was not identifiable. Our research suggests type
specific patterns of evolution and spread of HPV-16, 18, 31, and 35 both before and after the worldwide migrations of the last four centuries.
The high prevalence of highly carcinogenic HPV-16 AA variants, and the extensive diversity of HPV-18, 31, and 35 variants with unknown
pathogenic properties raise the possibility that HPV intra-type variation contributes to the high cervical cancer burden in Mexico.
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Persistent infection with ‘‘high-risk’’ human papilloma-
viruses (HPVs) is the primary cause of cervical cancer
(IARC, 1995; Liaw et al., 1999; Munoz, 2000; Schiffman
Fig. 1. Prevalence of HPV-16 and HPV-18 variants in a cohort from
Monterrey, Nuevo Leon, Mexico.
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epidemiological studies identified only HPV-16 and HPV-
18 as carcinogenic HPV types (see IARC, 1995, for a
review), 17 HPV types closely or remotely related to
HPV-16 are now considered as carcinogenic to the genital
mucosa (Munoz et al., 2003). The prevalence of cervical
cancer between different countries differs by about an order
of magnitude. Generally speaking, developed countries have
low and developing countries high incidences of cervical
cancer. It is still poorly understood whether these disparities
are mostly the result of access to better public healthFig. 2. Genomic variation of HPV-31 isolates from Mexico, Norway, South Africa,
the viral long control region. The variants are identified with the acronyms MX, N
identifying the specific sample within the local collections.systems in developed nations, or whether divergent risk
factors produce these different outcomes. Behavioral risk
factors for developing cervical cancer that synergize with
HPV infections include tobacco smoking, multiparity, use of
anti-ovulants, and possibly nutrition (Castellsague and
Munoz, 2003; Kjellberg et al., 2000; Moodley et al.,
2003), and some of these, notably multiparity, differ be-
tween developed and developing countries.
Yet another possibility is that different cohorts are
exposed to HPVs with differing pathogenic properties.
Numerous epidemiological studies have confirmed that the
same carcinogenic HPV types occur in all parts of the world
(Bosch et al., 1995). HPV-16 is in nearly all countries of the
world the most common HPV type, but the prevalence of
other HPV types differs geographically. For example, HPV-
45 is particularly common in West Africa, although HPV-39
predominates in Central and South America (Bosch et al.,
1995). It is not clear whether such quantitative differences in
the prevalence of HPV types contribute to the geographic
disparities of the disease. However, it is well known that all
HPV types occur in form of numerous genomic variants.
These variants differ from one another by 1–5% of their
nucleotide sequence (Ho et al., 1993; Ong et al., 1993;
Stewart et al., 1996; Yamada et al., 1997), although by
definition, the sequences between HPV types differ by at
least 10% (Chan et al., 1995). Data suggest that variants of
HPV-16 and possibly of other HPV types differ biologically
and in their carcinogenic potential (Berumen et al., 2001; daand the United States of America in a 523-bp genomic segment, the 3Vhalf of
W, SA, and US according to the respective country of origin, and a number
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2000; Villa et al., 2000; Xi et al., 1997; Xi et al., 1998), and
likely contribute to geographic disparities.
Some of us (I.E.C.M., R.O.L., A.R.M., J.F.G.G., and
H.A.B.S.) are participating in a large ongoing epidemiolog-Fig. 3. Phylogenetic tree of HPV-31 variants from Mexico, Norway, South Afri
acronyms MX, NW, SA, and US according to the respective country of origin, aical study that aims to establish the relative prevalence of
HPV types in women living in and around the city of
Monterrey in the Mexican state of Nuevo Leon to identify
high-risk HPV carriers for early intervention and to lay the
foundation for future DNA diagnostic services and vaccina-ca, and the United States of America. The variants are identified with the
nd a number identifying the specific sample within the local collections.
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where and is not the subject of this paper. At the present state
of this research, after investigating smears of 1200 patients,
who were consecutively sampled without prior cytological
diagnosis, we have identified HPV-16, 31, 18, and 35 as the
most prevalent HPV types with 112, 29, 20, and 7 samples
containing either of these types, respectively. It was the
objective of the research reported here to determine the
genomic variation of these four HPV types in this Mexican
cohort to assign HPV-16 and HPV-18 variants to previously
established intra-type phylogenetic trees, and to establish
phylogenetic trees for the little studied types HPV-31 and
HPV-35.
There is a strong evidence that evolutionary changes of
HPV genomes occur at a very small pace, as it takes
apparently several 10000–100000 years to generate about
1% sequence diversity (Chan et al., 1995; Ho et al., 1993;
Ong et al., 1993). There is no evidence for recombination
of HPV genomes that may confound a study of genomic
variation. The variants of HPV types differ from one
another by about 1% within genes and a few percent in
some hypervariable regions such as the long control region
(LCR) and part of the E2 gene (Hecht et al., 1995; Ho et
al., 1993; Ong et al., 1993). One has to conclude that
several hundred thousand years ago, when the human
species evolved, all HPV types were already in existence
with genomes very similar to those found today. Genetic
distances among HPV isolates of one or a few percent
evolved in parallel to the ethnic groups and the spread of
humans around the earth. As a consequence, certain
variants of HPV types predominated in defined and iso-Fig. 4. Genomic variation of HPV-35 isolates from Mexico, Norway, South Africa,
the viral long control region.lated ethnic groups, such as in the people who first
colonized the American continent 12000 years ago. In a
country with diverse ethnic origins such as Mexico, where
European immigrants mixed with native American Indians,
today’s population carries the HPV variants that were
originally specific for either ethnic group. Variants of
HPV types are best diagnosed by determining the sequence
of their LCR. Biological and pathological differences
between variants of any HPV type may originate from
these particular differences of the LCR. More often,
however, they may stem from functional differences
among mutant proteins. due to the linkage between the
corresponding genes and the LCR sequences, the latter are
nevertheless sufficient for identification of variants with
different biological properties.Results
Most HPV-16 variants of the Mexican population are of
American Indian origin
All HPV-16 isolates investigated so far belong to either
of six phylogenetic branches of HPV-16 variants, namely
two closely related African branches (Af1 and Af2), a
European branch (E) closely related to an East Asian branch
(As), and a branch with variants common in American
Indians, which also occur in parts of Asia (AA) and which
are closely related to variants specific for North American
Indians (NA). The E variants are typified by the original
HPV-16 reference clone, an isolate from a German patient,and the United States of America in a 893-bp genomic segment, the 3Vhalf of
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(genomic position 7450–7850) in a single position, 7521.
AA variants are characterized by mutations in the positions
7485, 7489, 7669, 7764, and 7786. These genomic positions
refer to the revised sequence of HPV-16. The position 7521
is identical to position 7519, and the other five mutations to
7483, 7487, 7667, 7762, and 7784 in the original phyloge-
netic classification (Ho et al., 1993).
We have detected in this Mexican cohort among 1200
smears 112 samples with HPV-16, 98 of these with variants
from the AA branch, and 14 with European variants (Fig. 1).
European and African HPV-18 variants in a Mexican cohort
The HPV-18 reference clone is a Brazilian isolate and
likely a representative of HPV-18 variants of American
Indians. The LCR of European variants differs from this
clone by mutations in the position 7529, 7567, 7592, and
7670, and African variants by additional 10 nucleotide
changes in a 320-bp segment (Ong et al., 1993). Maximal
differences between any two variants are 7.3%. Here, amongFig. 5. Phylogenetic tree of HPV-35 variants from Mexico, N15 Mexican isolates, we found 13 belonging to the European
cluster and 2 African variants (Fig. 1).
Mexican variants belong to both branches of a newly
determined intra-type phylogenetic tree of HPV-31
HPV-31 was with 29 samples, the second most common
HPV type in the Monterrey cohort. The genomic diversity of
HPV-31 isolates has never been studied. Therefore, we
amplified and sequenced from these isolates a 523-bp seg-
ment between the genomic positions 7527–137, which
included the homologous part with the viral enhancer of the
diagnostic 400-bp HPV-16 segment. In order to approach a
hypothesis about a potential ethnic origin of the Mexican
samples, we included in our analysis eight samples from
European patients (Norway) and six samples from African
patients or patients with mixed African ethnicity from South
Africa.
In all isolates together, we detected nucleotide exchanges
in 28 positions, and single nucleotide deletions in 7 additional
positions (Fig. 2) in altogether 25 different variants. Theorway, South Africa, and the United States of America.
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similar to that among HPV-16 variants (3.6%) (Fig. 2).
Phylogenetic trees, calculated either by the UPGMA or
the NJ algorithm, placed all HPV-31 variants on two
branches, one with all Norwegian variants and the original
German reference clone. The other branch contained no
European, but four of the six South African isolates. This
asymmetric distribution suggests that the first branch lumps
original European variants, the second one African variants.
The first and second branch contained 13 and 16 Mexican
and 1 and 2 US isolates, respectively (Fig. 3).
Several phylogenetic clusters of HPV-35 variants unite
Mexican, European and African isolates
HPV-35 was, with seven samples, the forth most common
HPV type in the cohort. The original HPV-35 clone has been
isolated in the United States, and the ethnicity of the patient
is unknown. The correct sequence of this HPV-35 isolate has
been published under the abbreviation HPV-35h (see http://
hpv-web.lanl.gov/stdgen/virus/hpv/compendium/htdocs/
HTML_FILES/HPVcompintro4.html#comp94 in Myers et
al., 1994), because a prior published sequence contained a
large number of sequencing errors. Since only a single
additional variant genome of this type has ever been reported
(Stewart et al., 1996), we compared the Mexican isolates
with 5, 10, and 5, respectively, HPV-35 samples from the
same European, African, and US cohorts that had entered the
HPV-31 study. For this comparison, we amplified an 893-bp
genomic segment between positions 7146 and 187, and
detected, in addition to the prototype, altogether 8 variants
with a total of 10 nucleotide exchanges and a 16-bp insertion
(Fig. 4). Maximal distances between any two variants were
five mutations (0.6%). These HPV-35 variants formed sev-
eral variant clusters rather than two- or three-branched trees
as HPV-16, 18, and 31 (Fig. 5). All Mexican and Norwegian
and three of the five US samples had a characteristic 16-bp
insertion and differed within and between the two geograph-
ic cohorts by a single point mutation. Absence of the 16-bp
insertion was specific for the reference clone and some of the
South African isolates. We found another isolate of the
reference clone a second time in the US, as well as another
variant without the insertion.Discussion
Our research shows that each of the four most prevalent
HPV types exists in this Mexican cohort in form of numer-
ous variants with significant genomic differences, which
raises the possibility that these variants exhibit intra-type
biological and pathogenic differences. Once DNA diagnosis
or vaccination programs are considered for this population, it
should be examined whether the diagnostic tools or epitopes
are affected by mutations elsewhere in the genomes of these
HPV-16, 18, 31, and 35 variants.All variants of HPV-16 could be unequivocally assigned to
either the European or the American Indian branch of the
HPV-16 phylogenetic tree. HPV-16 is the only type for whom
it is well confirmed by numerous epidemiological (Becker et
al., 1994; Berumen et al., 2001; Da Costa et al., 2002; Franco
et al., 1999; Giannoudis and Herrington, 2001; Giuliano et
al., 1999; Xi et al., 1997, 1998) and molecular biological
(Kammer et al., 2000; Villa et al., 2000) studies that genomic
variation correlates with altered biological and epidemiolog-
ical properties, which apparently result in increased carcino-
genicity of African and AA variants. Except in American
Indians and some Asian populations, AA variants are fre-
quent in peoples with an American Indian component (Beru-
men et al., 2001; Lizano et al., 1997), but elsewhere, they
were only found in Spain (Yamada et al., 1997), possibly
because of reverse migration from Latin America.
The prevalence of 88% of the HPV-16 AA variant in this
Mexican cohort is the highest ever detected in any part of
the world. This observation and data from the papers cited
above make it possible that exposure to the AA variants of
HPV-16 contributes to the increased risk of Mexican
women to develop cervical cancer. The high ratio of AA
variants in Nuevo Leon is astonishing, as a large part of the
population of this Mexican state is considered to be
ethnically of Spanish origin, and even among individuals
explicitly categorized as Mestizos, the admixture of Indian
genes has been measured as maximally 40%, with 55%
European and maximally 5% African genetic markers
(Cerda-Flores et al., 2002). As HPV-16 infects the vast
majority of all human populations, one might expect that
the spread of the virus follows similar characteristics as the
spread of host genes. It may be interesting to address the
question of whether behavioral components explain this
disparity, or whether HPV-16 AA variants spread more
efficiently than E variants.
Alternatively, it may be that migration has significantly
affected virus distribution in this region if groups that might
once be kept apart by vast distances are mixing sexually.
Population movements between Central American popula-
tions, Mexico, and Hispanic populations in the United States
are well documented, and these migrations likely increase
the chance of sexual contact between an e´migre´ and men or
women of the host culture. Ultimately, these social influen-
ces may heighten a Monterey woman’s risk for acquiring
viral variants that were historically absent or rare in this
population.
The number of HPV-18 samples is too low for any
conclusions. A predominance of European variants, as
observed, would be expected, and the presence of African
variants is a distinct possibility because of an ethnic African
element in this population. The absence of the HPV-18
prototype from these samples is noteworthy, as this is a
Brazilian isolate that had frequently been found again in
South American cohorts (Ong et al., 1993).
We determined phylogenetic trees of HPV-31 and 35
variants based on LCR segments of these viruses that
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HPV-16 and HPV-18 that had been used for phylogenetic
evaluations. HPV-31 variants are separated into two deep
phylogenetic branches. It seems likely that the first branch
with all European variants and 13 out of 29 Mexican isolates
represents typical European HPV-31 genomes. The second
branch with 4 of 6 African and 16 out of 29 Mexican
isolates are difficult to assess. It seems reasonable to suggest
that it may represent the original HPV-31 genomes of
American Indians, because it would be difficult to explain
a high prevalence of African isolates in a country with only
a very small fraction of African immigrants. This phyloge-
netic similarity of African and American Indian variants
would be somewhat reminiscent to the situation in HPV-16,
where American Indian (AA) and African variants are more
closely related to one another than to European variants.
HPV-35 variants fall into two categories, identified by
the presence or absence of a 16-bp segment absent from the
HPV-35 reference clone and four of nine African isolates.
As this distinction has to be counted as a single mutation,
this genomic difference as well as the generally low number
of nucleotide differences does not allow establishing a stable
tree for HPV-35 variants. Since all Mexican isolates are
identical to some European or some African isolates, this
cohort suggests that the HPV-35 type was either absent from
America in pre-Columbian times or that American Indian
HPV-35 variants were indistinguishable from those in
Europe and Africa.
About 30% of all malignant tumors in women in Mexico
are uterine cervix carcinomas (Gonzalez-Garay et al., 1992;
Hernandez-Avila et al., 1998; Silva et al., 1999; Torroella-
Kouri et al., 1998), making this cancer a leading oncological
concern of public health. While this high prevalence likely
will have some behavioral explanations and may also be
caused by lack of appropriate medical care (Lazcano-Ponce
et al., 1999a, 199b), our data raise the possibility that the
specific viral load, that is, a unique epidemic with variants
of HPV types that differ from those in Europe and the
United States, contributes to this problem.Table 1
Location and sequence of primers used in PCR amplification and sequencing rea
LCR HPV type Name Locat
HPV-16a 7478 7478
7841 7861
HPV-21 HPV31-8aF 7527
HPV31-8aR 114
HPV-18b 7485 7465
7805 7806
HPV-35 HPV35LCR-F 7146
HPV35LCR-R 163
HPV35LCRa-F 7418
HPV35LCRa-R 11
The HPV-16 and 18 primers have been introduced by Ho et al. (1991) and Ong
a Primers published by Ho et al. (1991).
b Primers published by Ong et al. (1993).Materials and methods
Clinical specimens and DNA preparation
Among a cohort of 1200 consecutive women from
several primary health care centers in Monterrey, Nuevo
Leon, Mexico, a total of 161 specimens were positive for
the four most common HPV types, namely 112 for HPV-
16, 29 for HPV-31, 20 for HPV-18, and 7 for HPV-35
positive samples. All of these samples entered this study
(designated as MX-Z, Z being the code number of the
patients), except five samples with HPV-18 with insuffi-
cient DNA. These samples had been taken in the form of
swabs during a large ongoing epidemiological study that
will be published elsewhere by some of us (I.E.C.M.,
R.O.L., A.R.M., J.F.G.G., and H.A.B.S., in preparation).
The 13 Norwegian swabs (NW-Z) were collected in Oslo,
Norway, during gynecological consultations of these
patients. Sixteen South Africa specimens (swabs) from
Cape Town excluded white patients but were from two
different ethnic groups that we refer to as black (SA*-Z)
and mixed race (SA-Z) women. For all three cohorts,
cytological diagnoses were done after obtaining these
samples, and the clinical outcome did not influence the
inclusion in this study. The samples from the United States
of America were obtained in Los Angeles and derived
from biopsies of anal neoplastic lesions in patients positive
for infection with the human immunodeficiency virus. The
use of these samples was approved by the Institutional
Review Board of the University of California Irvine, and
collection followed the respective patient protection rules
of each of the four participating clinics in Monterrey, Oslo,
Cape Town, and Los Angeles. Cervical DNA was extracted
and purified following standard techniques. Briefly, the
samples were digested with proteinase K, and the DNA
was purified with phenol–chloroform. The specific HPV
types were determined by PCR amplification with MY09/
11 primers and sequencing as previously described (Ber-
nard et al., 1994).ctions
ion Sequence (5V–3V)
–7477 GGGGTACCTCGGTTGCATGCTTTTTGGC
–7841 GGTCTAGACGGTTTGCACACACCCATGT
–7550 AGTAGTTCTGCGGTTTTTGGTTTC
–137 CCGAGGTCTTTCTGCAGGATTTTT
–7484 TCGGTTGCCTTTGGCTTATG
–7825 CGGTTGCATAAACTATGTAT
–7172 TATATTATGTGTTGTGGTGCCTGTTTG
–187 AATTTCATGGATGCTTTCTTCTACC
–7439 CGATTTCGGTTGCTGTTGGTAAG
–33 CGTTTTCGGTCACTCCCTGTTTT
et al. (1993).
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A major segment of the LCR region was amplified with
primer pairs specific for each HPV type. Table 1 lists
sequences and locations of the primers. Reaction mixtures
contained 20 mM Tris (pH 8.0), 100 mM KCl, 200 mM of
each deoxynucleoside triphosphate, 2 mM MgCl2, 10 mM
each of the sense and antisense oligonucleotide primer, and
1 unit of Taq DNA polymerase (Promega, Madison, WI),
although Go Taq DNA Polymerase (Promega) was used for
HPV-16 amplification. Forty amplification cycles were run
in the Eppendorff Master Cycler (Eppendorff, Hamburg,
Germany) with a 94 jC denaturing step (30 s), a 60 jC
annealing step (30 s), and a 72 jC extension step (1 min),
including a denaturing step of 4 min and a final extension of
5 min.
PCR products were visualized by ethidium bromide
agarose gel electrophoresis and purified by the QIAquick
gel extraction kit (Qiagen, Hilden, Germany). The products
were treated with 2 units of shrimp alkaline phosphatase and
10 units of exonuclease I (USB, Cleveland, OH) at 37 jC
for 1 h to clean the reaction from primers and dNTPs. The
enzymes were subsequently inactivated by heating at 72 jC
for 20 min. The products were sequenced using the BigDye
Terminator Cycle Sequencing kit (Perkin Elmer Applied
Biosystems, CA). For each sample, two independent PCR
products were generated and sequences from both orienta-
tions and internal primers (Table I) to exclude PCR artifacts.
Sequence changes that were found at least twice in the same
sample were counted as variants.
Sequence analysis
Sequence analysis was performed with ALIGN at the
GENESTREAM network server as published by Pearson et
al. (1997) to compare the HPV variant sequences with those
of the reference sequences. In this study, the nucleotide
positions of the HPV-18, HPV-31, and HPV-35 genomes
were numbered according the reference sequences NC
001357, NC 001527, and X74477, respectively. HPV-16
sequence and base positions are numbered according of the
last update of the HPV-16 reference genome sequence (Los
Alamos National Laboratory, http://hpv-web.lanl.gov/
stdgen/virus/hpv/compendium/htdocs/). The HPV-35 se-
quence reference used in this study was HPV-35H in the
same database, because of multiple errors in the original
HPV-35 sequence.
Phylogenetic analysis
HPV-16 and HPV-18 variants were compared with those
forming published phylogenetic branches (Ho et al., 1991,
1993; Ong et al., 1993; Stewart et al., 1996). Phylogenetic
analyses of HPV-31 and HPV-35 variants were performed
using MEGA version 2.1 as published by Kumar and
Gadagkar (2001). The phylogenetic trees were determined
I.E. Calleja-Macias et al.322using the unweighted pair-group method with arithmetic
average (UPGMA) and Neighbor joining (NJ) method.
Nucleotide-sequence accession numbers
The nucleotide sequences of all new HPV-31 and HPV-
35 variants have been entered into GenBank with the
accession numbers AY453865–AY454064.Acknowledgments
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